NLRP3 and Alzheimer disease: In the APP/PS1 AD mouse model, NLRP3 inflammasome activation results in the transformation of microglia from the M2 type (which promotes repair and clearance) to the M1 type (which is pro-inflammatory and neurotoxic), thereby reducing Aβ clearance and promoting its deposition [45].